Ingevity Corporation (NYSE:NGVT) Receives Consensus Rating of “Hold” from Brokerages

Ingevity Corporation (NYSE:NGVT) has been assigned a consensus rating of “Hold” from the five analysts that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating on the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $80.00.

A number of equities research analysts have commented on NGVT shares. BMO Capital Markets reiterated an “outperform” rating and issued a $83.00 price target on shares of Ingevity in a research report on Monday, March 2nd. Jefferies Financial Group restated a “buy” rating and set a $82.00 target price on shares of Ingevity in a research report on Thursday, February 26th. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research report on Tuesday, April 21st. Wells Fargo & Company upped their target price on Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Finally, Wall Street Zen upgraded Ingevity from a “hold” rating to a “strong-buy” rating in a research report on Saturday, May 9th.

Ingevity Trading Down 1.4%

NYSE NGVT opened at $66.64 on Tuesday. The business’s 50-day moving average price is $71.35 and its two-hundred day moving average price is $64.89. Ingevity has a 12 month low of $39.74 and a 12 month high of $79.29. The firm has a market capitalization of $2.32 billion, a PE ratio of -18.77 and a beta of 1.24. The company has a current ratio of 1.42, a quick ratio of 0.92 and a debt-to-equity ratio of 27.83.

Ingevity (NYSE:NGVT) last released its quarterly earnings results on Wednesday, May 6th. The company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The firm had revenue of $258.00 million for the quarter, compared to analyst estimates of $254.73 million. During the same quarter in the previous year, the company posted $1.01 EPS. The business’s revenue was up 4.1% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, analysts expect that Ingevity will post 5.05 EPS for the current year.

Institutional Investors Weigh In On Ingevity

Several institutional investors and hedge funds have recently made changes to their positions in the business. Segall Bryant & Hamill LLC boosted its position in shares of Ingevity by 1.2% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 1,298,661 shares of the company’s stock valued at $71,673,000 after purchasing an additional 15,451 shares in the last quarter. Millennium Management LLC boosted its position in shares of Ingevity by 1.3% during the 3rd quarter. Millennium Management LLC now owns 1,189,524 shares of the company’s stock valued at $65,650,000 after purchasing an additional 15,562 shares in the last quarter. Royce & Associates LP boosted its position in shares of Ingevity by 7.7% during the 4th quarter. Royce & Associates LP now owns 1,111,158 shares of the company’s stock valued at $65,758,000 after purchasing an additional 79,059 shares in the last quarter. Brown Advisory Inc. boosted its position in shares of Ingevity by 15.4% during the 4th quarter. Brown Advisory Inc. now owns 1,040,944 shares of the company’s stock valued at $61,603,000 after purchasing an additional 138,859 shares in the last quarter. Finally, Simcoe Capital Management LLC boosted its position in shares of Ingevity by 9.4% during the 4th quarter. Simcoe Capital Management LLC now owns 1,020,945 shares of the company’s stock valued at $60,420,000 after purchasing an additional 87,490 shares in the last quarter. Institutional investors own 91.59% of the company’s stock.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.